0.05Open0.05Pre Close0 Volume235 Open Interest5.00Strike Price0.00Turnover0.00%IV304.00%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma25.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
NRX Pharmaceuticals Stock Discussion
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic | NRXP Stock News
11 MINUTES AGO, 7:00 AM EDT
VIA PR NEWSWIRE
• Stability milestone supports submission of FDA New Drug Application by NRx for the use of intravenous ketamine to treat Suicidal Depression
• Ketamine is currently used off-label for this indication. However, FDA approval is typically required for patient...
HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
HOPE Therapeutics, Inc., a subsidiary of
https://www.moomoo.com/t/news/post/42897644/mbyzFRmrUf
Benzinga· 1 min ago
No comment yet